1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Hefei Tg Immunopharma Co. Ltd. has 1 pending office action. This matter is assigned to examiner HUYNH, PHUONG N. The portfolio involves 1 distinct examiner and 0 distinct art units. HUYNH, PHUONG N is the busiest examiner for the company, with 1 busiest examiner pending action.
The 0 distinct art units recorded is a specific characteristic of this portfolio. This 1 pending office action and the involvement of 1 distinct examiner constitute the entirety of the company's current active prosecution profile. HUYNH, PHUONG N oversees the 1 busiest examiner pending action as the primary point of contact.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUYNH, PHUONG N | 1 | 65.7% | +53.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18584875 | B7H6 ANTIBODY AND USE THEREOF | HUYNH, PHUONG N | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18584875 | B7H6 ANTIBODY AND USE THEREOF | HUYNH, PHUONG N | — | §102§112DP | Non-Final OA | — | Pending | Feb 22, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial